Gyre Therapeutics Dividend Yield Over Time
| GYRE Stock | 11.29 0.46 3.91% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Gyre Therapeutics Performance and Gyre Therapeutics Correlation. Gyre |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Gyre Therapeutics. If investors know Gyre will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Gyre Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.70) | Earnings Share (1.04) | Revenue Per Share 1.464 | Quarterly Revenue Growth (0.14) | Return On Assets 0.1018 |
The market value of Gyre Therapeutics is measured differently than its book value, which is the value of Gyre that is recorded on the company's balance sheet. Investors also form their own opinion of Gyre Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Gyre Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Gyre Therapeutics' market value can be influenced by many factors that don't directly affect Gyre Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Gyre Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Gyre Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gyre Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Dividend Yield Analysis
Compare Gyre Therapeutics and related stocks such as Alaska Air Group, Porvair plc, and Shake Shack Dividend Yield Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALK | 0.0092 | 0.0055 | 0.0055 | 0.0055 | 0.0084 | 0.0099 | 0.0124 | 0.0163 | 0.0211 | 0.0207 | 0.007 | 0.007 | 0.007 | 0.0081 | 0.0077 |
| SHAK | 0.0206 | 0.0206 | 0.0206 | 0.0206 | 0.0525 | 0.0525 | 0.0525 | 0.0525 | 0.0525 | 0.0525 | 0.0525 | 0.0525 | 0.0525 | 0.0604 | 0.0403 |
| YUM | 0.006 | 0.0242 | 0.0315 | 0.0315 | 0.0315 | 0.0298 | 0.0298 | 0.0147 | 0.0156 | 0.0166 | 0.0173 | 0.0144 | 0.0177 | 0.0185 | 0.0175 |
| WEN | 0.0195 | 0.0149 | 0.018 | 0.018 | 0.018 | 0.018 | 0.018 | 0.017 | 0.0221 | 0.0221 | 0.0221 | 0.0221 | 0.0221 | 0.0513 | 0.031 |
| PNR | 0.077 | 0.0362 | 0.0267 | 0.0185 | 0.0249 | 0.0386 | 0.0357 | 0.0292 | 0.0282 | 0.0158 | 0.0144 | 0.011 | 0.0187 | 0.0121 | 0.0115 |
| BJRI | 0.009 | 0.009 | 0.009 | 0.009 | 0.009 | 0.009 | 0.009 | 0.009 | 0.009 | 0.013 | 0.0 | 0.0 | 0.0 | 0.0 | 0.013 |
Gyre Therapeutics and related stocks such as Alaska Air Group, Porvair plc, and Shake Shack Dividend Yield description
Dividend Yield is Gyre Therapeutics dividend as a percentage of Gyre Therapeutics stock price. Gyre Therapeutics dividend yield is a measure of Gyre Therapeutics stock productivity, which can be interpreted as interest rate earned on an Gyre Therapeutics investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.My Equities
My Current Equities and Potential Positions
| Gyre Therapeutics | GYRE |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
null 11.29
Check out Gyre Therapeutics Performance and Gyre Therapeutics Correlation. For information on how to trade Gyre Stock refer to our How to Trade Gyre Stock guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Gyre Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.